Deltona’s request to add a fourth fire-based transport unit was denied by Volusia County, despite increasing call volumes and ...

Each department sets its own guidelines for use of AI Some Hillsdale professors ban the use of artificial intelligence while ...

Locals now have access to accurate, affordable drug tests in Mesa, AZ at RPT Labs, bringing tailored solutions for both individuals and businesses throughout the region. With comprehensive services ...

Amazon's introduction of API fees for third-party developers represents another margin squeeze on sellers, this time arriving indirectly through the software tools that have become essential to ...

Why is the revoking of 14 quality control orders (QCOs) on intermediate goods affecting textile value chain important for ...

Namagwa, S. (2025) Governance, Risk, and Regulation: A Framework for Improving Efficiency in Kenyan Pension Funds. Journal of ...

SAN DIEGO, Nov. 13, 2025 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today reported financial results for the third quarter ended September 30, 2025.

Third quarter 2025 net revenues were $17.6 million Emrosi total prescriptions increased 146% over the second quarter of 2025 Emrosi net revenues were $4.9 million Company to hold conference call today ...

Record annual revenue $28.37 billion, up 4 percent year over yearRecord annual GAAP EPS $8.66 and record non-GAAP EPS $9.42, up 1 percent and 9 ...

Bionano Genomics, Inc. (Nasdaq: BNGO) today reported financial results for the third quarter ended September 30, 2025. "Over the last year, we have taken ...